Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer
NORTHBROOK, Ill., May 21, 2014 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company focused on the development and commercialization of REXTORO, an oral testosterone (T) replacement product, today announced that Patrick Shea has joined the Company as Chief Commercial Officer.